Millennium Management
COGT icon

Millennium Management’s Cogent Biosciences COGT Stock Holding History

Millennium Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-20,300
Closed -$158K – 5934
2024
Q4 		$158K Buy
+20,300
New +$202K ﹤0.01% 5379
2024
Q3 		– Sell
-103,400
Closed -$872K – 6144
2024
Q2 		$872K Buy
+103,400
New +$784K ﹤0.01% 4193
2024
Q1 		– Sell
-100,000
Closed -$588K – 6240
2023
Q4 		$588K Buy
+100,000
New +$766K ﹤0.01% 4542

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Millennium Management's COGT Position: Q1 2026 in Review

Millennium Management reduced its Cogent Biosciences (COGT) stake by 1.3% in Q1 2026, selling an estimated $584K and leaving 1,192,406 shares worth $45.9M. The position accounts for 0.02% of the portfolio, ranked #883.

Millennium Management first reported a position in COGT in Q1 2018 and has held it in 27 quarters since. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Millennium Management held 1,192,406 shares of Cogent Biosciences worth $45.9M as of Q1 2026.
  • Millennium Management sold 15,822 Cogent Biosciences shares in Q1 2026, an estimated $584K.
  • Cogent Biosciences made up 0.02% of Millennium Management's portfolio in Q1 2026, its #883 holding.
  • Millennium Management first reported a position in Cogent Biosciences in Q1 2018 and has held it in 27 quarters since.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.